Catalytic precolumn derivatization of amikacin.
Lung
K R
KR
Analytical R&D, Pharmaceutical Research and Development, The DuPont Merck Pharmaceutical Company, Wilmington, DE 19880-0353, USA.
Kassal
K R
KR
Green
J S
JS
Hovsepian
P K
PK
D000583:Amikacin / Q000737:chemistry*; D000900:Anti-Bacterial Agents / Q000737:chemistry*; D002384:Catalysis; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D007202:Indicators and Reagents; D012015:Reference Standards; D015203:Reproducibility of Results
D000900:Anti-Bacterial Agents; D007202:Indicators and Reagents; D000583:Amikacin